OncoWuXi’s New Antibody Library Launch: An Innovative Step Forward in Drug Development

[Detection Antibodies + Target Development + High-Standard Controls] Empowering the Entire Drug Development Verification Process:

In 2024 the OncoWuXi database successfully upgraded to a pharmacology full-platform database. Following this upgrade, the database has undergone another significant innovation with the official launch of its new antibody library. This library integrates detection antibodies, novel target research, and high-standard control reagents, aiming to provide researchers with a full spectrum of tools to accelerate the development of innovative drugs.

Precision Detection, Empowering Drug Development Breakthroughs

Highlights at a Glance

 High-Specificity Detection Antibodies: Comprehensive coverage including anti-idiotype antibodies, anti-payload antibodies, and anti-tag antibodies, suitable for key applications in drug development such as efficacy evaluation and PK/PD analysis, with high reproducibility for ensuring data reliability;

 Forward-Looking Layout: Rapidly responding to new molecule detection needs, with the ROR1 antibody already available, and new target reagents like INHBE, PBD, eribulin, and doxorubicin coming soon;

 High-Standard In Vivo Reagents: Optimized low-endotoxin (≤1 EU/mg) isotype control antibodies for animal experiments, rigorously validated in animal models with a batch stability traceability system for ensuring data reliability;

 GPCR Antibody Matrix: Offering a variety of GPCR target-related antibodies to support membrane protein research and complex target development needs.

User-Oriented, Continuous Innovation

The OncoWuXi team at WuXi Biology consistently adheres to a “user demand-oriented” philosophy, swiftly responding to various new target development needs, and we will continue to update the OncoWuXi antibody library. If you have custom antibody requirements or other challenges, feel free to contact us.

Experience Now: We cordially invite you to visit OncoWuXi’s New Antibody Library to explore more exciting features and content.

Follow Us on LinkedIn Link